









Markets
/
Stocks
/
nasdaq-xoma
/

XOMA Royalty Corp

XOMA

30.250USD

+0.080+0.27%

Close 03/30, 16:00（ET）Quotes delayed by 15 min

361.56MMarket Cap

19.74P/E TTM



XOMA Royalty Corp

30.250

+0.080+0.27%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of XOMA Royalty Corp

Currency: USD Updated: 2026-03-27

Key Insights

XOMA Royalty Corp's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 26 out of 80 in the Media & Publishing industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 65.75.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

XOMA Royalty Corp's Score

Industry at a Glance

Industry Ranking

26 / 80

Overall Ranking

159 / 4542

Industry

Media & Publishing

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

XOMA Royalty Corp Highlights

StrengthsRisks

XOMA Royalty Corporation is a biotechnology royalty aggregator. The Company’s royalty aggregator business is primarily focused on early to mid-stage clinical assets, primarily in Phase I and II, with significant commercial sales potential that are licensed to funded partners. The Company has a portfolio of economic rights and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The Company's commercial assets include OJEMDA (tovorafenib), IXINITY, XACIATO, VABYSMO (faricimab svoa), DSUVIA (sufentanil sublingual tablet), and MIPLYFFA (arimoclomol). Its Phase III assets include Rilvegostomig (AZD2936), Ficlatuzumab (AV-299), Ovaprene, D-Fi (FCX-007), Seralutinib, Cetrelimab (JNJ-63723283), Ersodetug (RZ358), and Mezagitamab (TAK-079). Its Phase II assets include Acimtamig (AFM13), AFM24, Vosaroxin, Aldoxorubicin, G03-52-01, PBF-680, PBF-677, Vidutolimod (CMP-001), and RZ-402. Its others assets include COM902 and MT-0169.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 996.03% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 52.15M.

Turnaround to Profit

The company's performance has turned profitable, with the latest annual net income of USD .

Overvalued

The company’s latest PE is 19.68, at a high 3-year percentile range.

Held by PRFDX

Star Investor PRFDX holds 921.00 shares of this stock.

Analyst Rating

Based on 5 analysts

Buy

Current Rating

65.750

Target Price

+115.36%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-27

The current financial score of XOMA Royalty Corp is 6.75, ranking 54 out of 80 in the Media & Publishing industry. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 13.76M, representing a year-over-year increase of 57.87%, while its net profit experienced a year-over-year increase of 162.29%.

Score

Industry at a Glance

Previous score

6.75

Change



Financials

8.25

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

6.59

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

6.84

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

5.01

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.09

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

XOMA Royalty Corp's Company Valuation

Currency: USD Updated: 2026-03-27

The current valuation score of XOMA Royalty Corp is 7.13, ranking 54 out of 80 in the Media & Publishing industry. Its current P/E ratio is 19.68, which is 115.04% below the recent high of 42.33 and 292.11% above the recent low of -37.82.

Score

Industry at a Glance

Previous score

7.13

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 26/80

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-27

The current earnings forecast score of XOMA Royalty Corp is 8.00, ranking 19 out of 80 in the Media & Publishing industry. The average price target is 58.00, with a high of 104.00 and a low of 50.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 5 analysts

Buy

Current Rating

65.750

Target Price

+117.93%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

XOMA Royalty Corp

XOMA

Roku Inc

ROKU

Paramount Global

PARA

Live Nation Entertainment Inc

LYV

TKO Group Holdings Inc

TKO

Paramount Skydance Ord Shs Class B

PSKY

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-27

The current price momentum score of XOMA Royalty Corp is 9.39, ranking 2 out of 80 in the Media & Publishing industry. Currently, the stock price is trading between the resistance level at 32.95 and the support level at 25.93, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

9.50

Change

-0.11

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(3)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.584

Buy

RSI(14)

66.522

Neutral

STOCH(KDJ)(9,3,3)

74.653

Neutral

ATR(14)

1.620

High Vlolatility

CCI(14)

66.074

Neutral

Williams %R

21.627

Buy

TRIX(12,20)

0.634

Sell

StochRSI(14)

49.307

Sell

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

30.074

Buy

MA10

29.196

Buy

MA20

27.889

Buy

MA50

26.442

Buy

MA100

28.010

Buy

MA200

29.781

Buy

Institutional Confidence

Currency: USD Updated: 2026-03-27

The current institutional shareholding score of XOMA Royalty Corp is 5.00, ranking 33 out of 80 in the Media & Publishing industry. The latest institutional shareholding proportion is 67.32%, representing a quarter-over-quarter decrease of 1.29%. The largest institutional shareholder is The Vanguard, holding a total of 701.66K shares, representing 5.89% of shares outstanding, with 53.62% increase in holdings.

Score

Industry at a Glance

Previous score

5.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

BVF Partners L.P.

2.59M

Morgan Stanley Investment Management Inc. (US)

1.64M

+7.29%

Fidelity Management & Research Company LLC

1.04M

-0.17%

The Vanguard Group, Inc.

Star Investors

668.11K

+4.59%

BlackRock Institutional Trust Company, N.A.

544.18K

+0.75%

Opaleye Management Inc.

255.09K

Woodline Partners LP

209.94K

+16.49%

Geode Capital Management, L.L.C.

211.98K

+4.11%

Hughes (Owen P.)

98.56K

+56.46%

State Street Investment Management (US)

167.03K

+8.83%

Risk Assessment

Currency: USD Updated: 2026-03-27

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Media & Publishing domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of XOMA Royalty Corp is 3.65, ranking 44 out of 80 in the Media & Publishing industry. The company's beta value is 0.72. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. XOMA Royalty Corp’s latest ESG disclosure leads the Media & Publishing industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.